. The gates are in turn guarded by regulatory AAA (ATPases associated with diverse cellular activities) complexes that are responsible for recognizing substrate proteins as well as for unfolding and translocating them into the protease cage 3, 4 . In eukaryotes, substrate selection depends on a range of ubiquitin ligases that mark substrates with a polyubiquitin tag, a degradation signal recognized by the AAA regulatory particle of the 26S proteasome 5, 6 . An analogous system involving the protein modifier Pup targets substrates to the eukaryotic-like core proteasome present in mycobacteria and closely related species 7, 8 . However, it is not known whether the ATP-dependent Clp proteases, which are found in almost all bacteria, require a general post-translational tagging system. The Clp complexes are thought to use the N-terminal domains (NTD) of the AAA ATPases (ClpA, ClpC, ClpE or ClpX) to recognize specific degradation motifs, known as degrons, which are typically located at the N-or C-terminal ends of target proteins [9] [10] [11] . These degrons can also be introduced by the specialized SsrA tagging system, which is used for rescuing stalled ribosomes 12 . Alternatively, substrate recruitment may be aided by adaptor proteins that tether selected substrate proteins to the Clp proteolytic complex, thus facilitating their degradation 9 . In B. subtilis and other Gram-positive bacteria, the ClpC-ClpP (ClpCP) protease, which is constituted by the AAA unfoldase ClpC and the protease ClpP, is an important proteolytic machine for eliminating unfolded and aggregated proteins. The ClpCP proteolytic complex is under the control of McsB, the founding member of a class of protein kinases targeting arginine residues 13 . First, McsB controls the amounts of ClpCP in the cell by phosphorylating and inhibiting the transcriptional repressor CtsR [13] [14] [15] , which in turn regulates clpC and clpP gene expression 16 . Second, McsB has been reported to function as an adaptor protein of ClpC by stimulating its ATPase activity and promoting degradation of the CstR substrate 17, 18 . In addition to regulating CtsR and ClpC, McsB phosphorylates hundreds of diverse proteins in vivo, as revealed by B. subtilis phosphoproteomic analyses 15, 19 . This promiscuous activity suggested a more general function of the protein arginine kinase in the stress response of Gram-positive bacteria.
ClpCP degrades pArg proteins in vivo
Arginine residues are frequently observed at molecular interfaces crucial for protein folding and assembly 20 . Therefore, arginine phosphorylation, resulting in a net-charge inversion, is predicted to have a strong effect on protein stability. Of note, the kinase catalysing this reaction, McsB, has many substrates in vivo and is transcriptionally co-regulated with ClpP, the major protease of B. subtilis. We thus proposed that arginine phosphorylation may have a direct role in the degradation of aberrant proteins. To test this assumption, we monitored the fate of phosphoarginine (pArg) proteins in vivo by expressing an inactive trapping variant of the ClpP protease (Ser98Ala, ClpP TRAP ; refs 10, 21). Substrates captured within the protease cage can be co-purified and analysed by mass spectrometry (MS). To perform the pull-down experiments in the wild-type B. subtilis background, we engineered a ClpP mutant that does not interact with the endogenous, active protease. For this purpose, we exchanged residues of an ion pair at the interface of the ClpP heptamer. The resulting cross mutant (Glu119Arg/Arg142Glu, ClpP X ) did not form heterooligomers with wild-type ClpP, but maintained the ability to assemble a substrate-trapping cage (Extended Data Fig. 1 ).
Quantitative MS analysis of ClpP pull-downs from heat-shocked bacteria (Extended Data Fig. 2a , b, strategy illustrated in Fig. 1a ) revealed a large number of proteins that were specifically captured by the ClpP X-TRAP mutant ( Fig. 1b and Supplementary Table 1 ). Despite the technical difficulties in identifying arginine phosphorylations . The almost complete absence of ClpP-trapped pArg proteins in Δ clpC bacteria is even more remarkable, as the deletion of ClpC increases the overall amounts of pArg proteins. Despite the presence of YwlE, a highly active arginine phosphatase preventing pArg identification in B. subtilis wild-type cells 15, 19, 24 , phosphoproteomics analysis of Δ clpC cell lysates revealed 25 pArg sites (Supplementary Table 3 ). This finding highlights the active role of ClpC in directing pArg proteins to ClpPdependent proteolysis. Consistent with the proposed model, Δ clpP B. subtilis cell extracts also accumulated pArg proteins (Supplementary Table 4 ). To estimate the fraction of pArg proteins among the ClpP substrates, we analysed the overlap of the ClpP degradome (as defined by our pull-down experiments) and the pArg proteome (sites detected previously 15, 19, 25 and in the Δ clpP mutant strain). Accordingly, 25% of the proteins degraded by ClpP are substrates of McsB and thus potential candidates of the pArg-dependent degradation pathway (see also Supplementary Discussion and Extended Data Fig. 2c ).
Protein phosphorylation stimulates ClpCP
To analyse how ClpC selects pArg-containing substrates, we reconstituted the ClpCP-McsB system in vitro. McsB was previously described as an adaptor of ClpC targeting the transcriptional repressor CtsR for ClpCP-mediated proteolysis 17, 18 . Although the kinase activity of McsB was shown to be required for CtsR degradation, it was not clear whether McsB itself, the substrate or the ClpCP protease became phosphorylated, and how this phosphorylation event enhanced protease activity. We thus recapitulated the corresponding kinase and protease assays using the intrinsically unfolded protein β -casein as a model substrate. We observed that the ClpCP protease complex alone was not active. However, in the presence of MecA, a well-characterized ClpC adaptor 26 , the substrate was efficiently hydrolysed (Fig. 2a) . Similarly, McsB induced the degradation of β -casein by ClpCP. The stimulatory effect was enhanced by the MscB activator McsA 27 , which showed no effect on casein degradation by itself (Fig. 2a) . To test whether the kinase activity of McsB is required for β -casein degradation, we used an inactive mutant of McsB (Glu212Ala; ref. 13), and, in parallel, probed the effect of the YwlE arginine phosphatase. Both kinase inactivation and phosphatase addition prevented substrate degradation (Fig. 2b, c) , highlighting the importance of the arginine kinase activity of McsB for activating the ClpCP protease. This functional coupling is also reflected in the different kinase activities of the tested McsB variants (Fig. 2a) .
pArg is a degradation tag for ClpCP
To explore the stimulatory effect of McsB further, we performed degradation assays in the presence of the free amino acid phosphoarginine (pArg AA , in which ' AA' denotes the amino acid). We reasoned that pArg AA may compete with, and thus reveal, the pArg-dependent activation event. When incubated with McsB and ClpCP, pArg AA reduced the rate of β -casein degradation (Fig. 3a) . We next explored the influence of pArg AA on β -casein degradation by the ClpCP-MecA complex that should operate in a phosphorylation-independent manner. Unexpectedly, however, pArg AA also inhibited (and to a greater extent) the activity of the MecA-stimulated ClpCP protease (Fig. 3b) . By contrast, unphosphorylated arginine or phosphate did not block degradation. As it is known that effector proteins such as MecA dock to the NTD of AAA unfoldases, we monitored how pArg AA influences this interaction (Fig. 3c) (control) and ClpP X-TRAP pull-downs after expression in a B. subtilis wild-type (WT) strain. Proteins were considered as ClpP substrates (shaded area) when the X-TRAP/control relative protein intensity (x axis) was > 2 and the corresponding limma P value (y axis) was < 0.05. Phosphorylated proteins are shown as filled squares (red: pArg, blue: pSer/Thr/Tyr). In a few cases, the phosphorylated residue could not be unambiguously localized. As the same phosphopeptides have been observed to contain a pArg in previous experiments, they are labelled as probably pArg (open red squares). Identified pArg proteins are listed on the left. c, Volcano plots of the ClpP pull-downs performed in B. subtilis wild-type and Δ clpC strains in parallel. For comparison, pArg proteins identified in the B. subtilis wild-type pull-downs are marked in orange in the Δ clpC plot. Here and in the following, a quantification of the β -casein band is presented (original SDS-PAGE gels in Supplementary Fig. 2 
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MecA and ClpC, probably by competing with MecA for the same binding site. When probing the direct interaction between pArg AA and ClpC by isothermal titration calorimetry (ITC), we measured dissociation constants (K d values) of 60 μ M for full-length ClpC and 13 μ M for the isolated NTD (Fig. 3d) . The pronounced specificity for pArg AA was confirmed by measuring the interaction with related compounds, which did not bind (pTyr AA , arginine) or did so only weakly (phosphate). Moreover, we observed that pArg AA did not bind to MecA, and has a very low affinity (K d > 1 mM) for McsB (Extended Data Fig. 3 ). Finally, we tested the binding of pArg AA to the NTD of ClpA, the closest homologue of ClpC in Gram-negative bacteria, which lack a protein arginine kinase. Because no binding was observed (Extended Data Fig. 3) , the ability to recognise pArg AA with high specificity seems to be a unique property of the ClpC unfoldase.
The pArg-binding site of ClpC could have two possible functions in protein degradation. It could serve as a docking site for the autophosphorylated form of McsB, which functions as an adaptor, or, alternatively, it could directly recognize pArg-containing substrates. To distinguish between these two possibilities, we enzymatically prepared pArg-modified β -casein (casein pArg ) ( Fig. 4a and Extended Data Fig. 4) . A pull-down assay showed that casein pArg , but not unphosphorylated casein, binds to the ClpC NTD (Fig. 4b) (Fig. 4d) . Together, these data show that the pArg modification is crucial for recruiting substrates to the NTD of ClpC and for promoting assembly of the functional ClpCP protease complex.
To confirm the role of pArg as a degradation signal for the ClpCP protease, we analysed the digestion of substrate proteins that were argininephosphorylated to different degrees. For this purpose, we pre-incubated β -casein with McsB for increasing time intervals (Fig. 4e) . ClpCP degradation assays of the resulting casein/casein pArg mixtures showed a direct correlation between the amount of phosphorylated substrate and the extent of degradation ( Fig. 4e and Extended Data Fig. 4e ). Consistently, adding YwlE phosphatase to the pArg-modified substrates abolished their degradation. These results unambiguously demonstrate that ClpCP selectively degrades casein pArg and does not recognize pArg-less proteins as substrates.
The pArg docking sites of ClpC
To visualize how pArg binds to ClpC, we performed co-crystallization experiments of the NTD from B. subtilis ClpC with pArg AA . The co-crystal structure was determined at 1.6 Å resolution (Extended Data Table 2 ) and, consistent with the symmetrical nature of the NTD protein fold 28 (Fig. 5a ), revealed two almost identical pArg-binding sites (Fig. 5b, c) . Mapping the electrostatic potential of the NTD on its molecular surface illustrates the 'bipolar' architecture of the pArg-binding site that distinguishes it from pSer/Thr or pTyr binding sites (Extended Data Fig. 5 ). Such organization is perfectly suited for simultaneously recognizing the positively charged guanidinium and the negatively charged phosphoryl group. The functional importance of the pArg recruitment is reflected by the exact conservation of the interacting residues in ClpC proteins from other Gram-positive species (Extended Data Fig. 6 ). Since the structural data suggest that the ClpC hexamer has 12 pArg-docking sites, we asked how many pArg tags per substrate are required for degradation. Native MS analysis of the casein pArg sample that resulted from prolonged incubation with McsB and that was completely degraded after ClpCP incubation revealed a mixture of mono-and di-phosphorylated molecules (Extended Data Fig. 7 ). Given the efficiency of also cleaving less phosphorylated substrates ( Fig. 4f) , we suppose that proteins carrying a single pArg mark can be degraded by ClpCP.
Notably, the identified pArg-binding sites match the MecA-binding grooves observed in the MecA-ClpC complex 29 , with the phosphoryl moieties of pArg AA binding in place of the MecA glutamate residues 184 and 198 (Fig. 5d ). This overlap explains the inhibition of MecA-ClpCP by pArg AA , as observed in our functional studies. Importantly, pArg AA binds to ClpC glutamate residues 32 and 106, which in the MecA-ClpC complex remain unbound. Therefore, the bipolar architecture of the pArg-binding sites can only be fully explored by the phosphoguanidinium moiety, whereas the MecA glutamate residues only dock into the positively charged half. To test the structurally characterized binding mode experimentally, we prepared NTD mutants carrying an Glu32Ala/Glu106Ala double mutation (EA) and measured the interaction with MecA and pArg AA . As predicted, mutating the two glutamate residues abolished pArg AA binding (Extended Data Fig. 3 ) but did not impair the interaction with MecA (Fig. 3c) . Consistent with the binding data, the corresponding ClpCP EA protease efficiently degraded protein substrates with the help of MecA, but failed to degrade substrates in a pArg-dependent manner (Fig. 5e, f) . To confirm the selective failure in recognizing and degrading pArg protein, we measured the ClpC ATPase activity, which, in analogy to other AAA unfoldases 30 , should be stimulated by substrates. We observed that purified casein pArg could stimulate the ATPase activity of wild-type ClpC to a similar extent to MecA (Fig. 5g) . In strong contrast, the ATPase of the ClpC EA mutant could be induced by MecA, but not by casein pArg , confirming the selective loss of pArg-dependent functions in this mutant.
Biological role of the pArg-ClpCP system
The developed ClpC EA mutant represents a valuable tool for addressing the biological role of pArg-dependent protein degradation. To this end, we analysed the ability of the ClpC EA mutant to suppress growth defects of a Δ clpC strain at increased temperatures (Fig. 6a) . Whereas the expression of wild-type ClpC from a plasmid restored thermotolerance and even made the bacteria more robust in surviving increased temperatures, expression of the ClpCP EA mutant could not rescue the bacteria. As the ClpCP EA mutant is fully functional as a protease and can team up with adaptor proteins, these data highlight the essential role of the pArg-dependent degradation pathway in surviving proteotoxic stress situations.
Discussion
Energy-dependent proteases are essential for all living organisms to carry out protein quality control and degrade short-lived regulatory proteins. In contrast to eukaryotes, which universally use polyubiquitin chains for marking target proteins, a general post-translational modification regulating proteolysis in bacteria is not known. Here, we characterize such a tagging system. We show that pArg is a degradation mark for the ClpCP proteolytic machine, present in most Grampositive species. Despite differing in size, the bacterial pArg modifier shares several features with the eukaryotic polyubiquitin degradation tag. First, both pArg and polyubiquitin are post-translationally attached to substrates, allowing for dynamic regulation of degradation that is not available to mechanisms relying on sequence-encoded degrons. Second, the pArg mark is recognized by highly specific receptor sites on the NTD of ClpC (Fig. 6b) , as is ubiquitin by special receptor proteins of the 19S regulatory particle. Third, owing to charge inversion, the phosphorylation of arginine residues is predicted to destabilize the native structure of substrate proteins, priming them for subsequent catalysed unfolding. Similarly, the polyubiquitin tag affects the structure and stability of marked proteins 31 . Fourth, the pArg tag is reversibly attached to substrate proteins. As enzymes building polyubiqutin chains are opposed by de-ubiquitinases, the activity of the McsB kinase is counteracted by the pArg-specific phosphatase YwlE, thus allowing for regulation of the pArg degradation pathway.
In addition to revealing the pArg degradation tag, our study clarifies the mechanism of the ClpCP protease. Notably, ClpC has been reported to be a unique AAA enzyme that requires accessory proteins to assemble its functional hexameric form 32 . The present data suggest that this model is not fully correct, as the degradation of pArg-containing 
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substrates does not require any additional co-factors. Substrate recruitment itself induces the ATPase activity of ClpC and promotes assembly of the functional ClpCP complex. Similar to the eukaryotic 26S proteasome, binding of specifically marked substrates is thus directly linked to protease activation. On the basis of the described functional similarities, the discovered pArg-ClpCP system seems to represent a simple bacterial version of the eukaryotic ubiquitin-proteasome system.
Our study also provides important insights into the biological role of pArg as a degradation tag. Analysis of the in vivo ClpP degradome suggests that the pArg tag is crucial not only for the regulatory proteolysis of CtsR but also for general turnover of structurally and functionally diverse proteins. Furthermore, we observed that pArg-dependent protein degradation is vital for coping with proteotoxic stress (Fig. 6a) , and that pArg proteins are markedly enriched in the aggregate fraction of B. subtilis cells (Supplementary Tables 4 (Δ clpP) and 5 (wild-type)). Of note, 50% of the in vivo phosphorylated proteins 15, 19 carry the phosphomark in a region predicted to adopt a defined secondary structure, that is, in an α -helix or β -strand. Presumably, these sites would only be accessible to McsB when present in an at least partially unfolded state, indicating that McsB might target the damaged form of those proteins. Consistent with this, a recent in vivo study points to the importance of the McsB kinase for removing aberrant proteins in B. subtilis: the deletion of the kinase led to the accumulation and aggregation of an unstable model protein, while the levels of a stably folded counterpart of this model protein were not influenced 33 . We thus presume that protein arginine phosphorylation may have a role in the quality control of bacterial proteins, targeting unstable and aggregation-prone proteins for ClpCP degradation. Modifying arginine of all amino acids to decide about the fate of aberrant proteins seems to make sense. As arginine-rich patches correlate with aggregation propensity 34 , adding a phosphoryl group to arginine residues could hinder aggregation and, at the same time, promote the clearance of such problematic protein species by co-working protease machines.
Online Content Methods, along with any additional Extended Data display items and Source Data, are available in the online version of the paper; references unique to these sections appear only in the online paper. ) and spectinomycin (100 μ g ml −1
) were added, respectively. E. coli and B. subtilis cultures containing the pHCMC05-derived plasmids were cultured in the presence of ampicilin (50 μ g ml
) and chloramphenicol (10 μ g ml
), respectively. E. coli BL21 (DE3) containing pET21-or pET SUMO-derived vectors were cultured in the presence of ampicilin (50 μ g ml
−1
). In vivo pull-downs using ClpP trapping mutants. For the ClpP X-TRAP pull-down experiment in the wild-type background of B. subtilis (Fig. 1b), 6 independent B. subtilis cultures were grown in LB media expressing either ClpP X (3 control cultures to identify unspecific binding partners) or ClpP X-TRAP (3 sample cultures). After the cells were grown at 37 °C until mid-exponential phase, expression of His-tagged ClpP X or ClpP X-TRAP proteins was induced with 1 mM IPTG. Recombinant protein expression proceeded for 3 h at 37 °C. To induce the activity of heat-shock proteins, including McsB and various Clp ATPases, the cultures were incubated in a pre-warmed incubator at 45 °C for 45 min. Cells were collected by centrifugation, resuspended in lysis buffer (25 mM Tris, pH 7.5, 150 mM NaCl, 10% glycerol) and stored at − 80 °C. For the pull-down experiment comparing ClpP-trapped proteins in wild-type and Δ clpC backgrounds (Fig. 1c) , the same procedure was applied using 12 independent B. subtilis cultures (3 wild type with ClpP ). The thawed cell suspensions were incubated for 1 h on ice with 2 mg ml −1 lysozyme (Sigma), Complete protease inhibitor cocktail (Roche), 0.2 mM PMSF (Sigma) and 10 μ g ml −1 DNase (Sigma). Cells were sonicated and the resultant lysate was cleared by centrifugation at 4 °C. For the purification of 6His-tagged ClpP, the lysate was incubated with Dynabeads His-Tag Isolation & Pulldown (Invitrogen) for 1 h at 4 °C. The beads were then washed 5× with lysis buffer and 2× with lysis buffer containing 50 mM imidazole. Two aliquots (5 or 10%) of the resulting beads were collected for SDS-PAGE analysis (protein elution with denaturing SDS-PAGE sample buffer) or Tris-acetate native-PAGE (protein elution with lysis buffer containing 500 mM imidazole). The remaining beads were subjected to reduction with 2 mM DTT (56 °C, 40 min), alkylation with 10 mM iodoacetamide (room temperature, in the dark, 45 min), and digestion with 2.5 μ g Trypsin Gold (Promega) at 37 °C for 12 h.
MALDI-MS analysis of ClpP purifications.
To analyse the mass of B. subtilis proteins co-purifying with ClpP(6His) under heat-shock conditions (Extended Data Fig. 1 ), matrix assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF-MS) was performed. The corresponding protein purifications were spotted on a MALDI plate using a sinapinic acid (10 mg ml −1 ) matrix prepared in 50% acetonitrile (ACN) and 0.1% trifluoroacetic acid (TFA). The samples were measured in a 4800 MALDI-TOF-TOF (AB Sciex) instrument operated in linear mode. Calibration was performed internally using cytochrome c as standard. Sample preparation for phosphoproteomic analysis. For the phosphoproteomic analysis of total cell extracts of B. subtilis Δ clpC, cells were lysed by sonication in buffer 4% SDS, 100 mM Tris, pH 7.5, 100 mM DTT and further processed using a filter aided sample preparation (FASP) 38 modified method, as described previously 15 , followed by trypsin digestion at 37 °C for 12-16 h. Protein aggregates were dissolved in the SDS buffer and processed in the same manner. Trypsin digestion completion was inspected by retention time and UV intensity (214 nm) distribution upon reverse-phase high-performance liquid chromatography (RP-HPLC) separation of a 0.1% aliquot of the resulting supernatants on a monolithic column (Ultimate Plus equipped with a PepSwift PS-DVB column, 5 cm × 200 μ m, DionexThermo-Fisher).
For the ClpP in vivo pull-down assays, a small aliquot (0.5%) of the on-bead trypsin digests was collected for subsequent quantitative analyses of co-purified proteins. The biological replicates were then pooled and further processed for phosphorylation analysis. Before phosphopeptide enrichment, sample digests were purified from buffer reagents by RP-C18 solid phase extraction at neutral pH using Oasis HLB cartridges (Waters). A previously described TiO 2 protocol 15 , optimized in accordance to the acid-labile nature of phosphoarginine, was used for phosphopeptide enrichment. LC-MS/MS analysis. Reverse-phase separation of all peptide mixtures was carried out on an Ultimate 3000 RSLC nano-flow chromatography system (Thermo Scientific), using 0.5% acetic acid (pH 4.5 with NH 3 ) as loading solvent, to prevent phosphoarginine hydrolysis during removal of salts in the pre-column (PepMapAcclaim C18, 5 mm × 0.3 mm, 5 μ m, Thermo Scientific). Peptide separation was achieved on a C18 separation column (PepMapAcclaim C18, 50 cm × 0.75 mm, 2 μ m, Thermo Scientific) by applying a linear gradient from 2% to 35% solvent B (80% ACN, 0.08% formic acid) in 120 or 240 min (pull-down and total extract samples, respectively) at a flow rate of 230 nl min −1
. Solvent A was 2% ACN, 0.1% formic acid. The separation was monitored by UV detection and the outlet of the detector was directly coupled to the nano-electrospray ionization source (Proxeon Biosystems) for MS analysis.
For phosphorylation analysis, TiO 2 elution samples were infused into the LTQ Orbitrap Velos Pro ETD mass spectrometer (Thermo Scientific) using PicoTip nanospray emitter tips (New Objective) at a voltage of 1.5 kV. Peptides were analysed in data-dependent fashion in positive ionization mode, applying two different fragmentation methods: collision-induced dissociation (CID) and electron-transfer dissociation (ETD). The survey scan was acquired at resolution 60,000 and the 6 most abundant signals with charge state equal or higher than 2+ and exceeding an intensity threshold of 1,500 counts were selected for peptide fragmentation analysis. For MS/MS experiments, precursor ions were isolated within a 2.1-Da window centred on the observed m/z. To prevent repeated fragmentation of highly abundant peptides, selected precursors were dynamically excluded for 30 s from MS/MS analysis. CID fragmentation was achieved at normalized collision energy (NCE) of 35% with additional activation of the neutral loss precursor at M-49, M-32.7 and M-98 amu in a standard multistage activation method. For ETD, peptides were incubated with fluoranthene anions allowing for charge-state-dependent incubation times (90 ms for 3+ charged peptides), and resulting peptide fragments were detected in the ion trap analyser.
For the identification of co-purified proteins in the ClpP in vivo pull-down assays, slightly different instrument settings were used. The 12 most abundant signals with charge state equal to or higher than 2+ and exceeding an intensity threshold of 500 counts were selected for CID peptide fragmentation analysis, applying an isolation window of 2 Da. Multistage activation was disabled. Selected precursors were dynamically excluded for 60 s from MS/MS analysis. Each pulldown digest was analysed twice, to evaluate technical reproducibility. MS data analysis. For the phosphorylation analysis of TiO 2 -enrchiment samples, raw data were extracted by the Proteome Discoverer software suite (version 1.4.0.288, Thermo Scientific) and searched against a combined forward/reversed database of B. subtilis Uniprot Reference Proteome with common contaminants added (4,455 entries in total) using MASCOT (version 2.2.07, Matrix Science). Carbamidomethylation of cysteine was set as fixed modification. Phosphorylation of serine, threonine, tyrosine and arginine plus oxidation of methionine were selected as variable modifications. Since tryptic cleavage is impaired at phosphorylated arginine, a maximum of two missed cleavage sites was allowed, whereas fully tryptic cleavage of both termini was required. The peptide mass deviation was set to 5 p.p.m.; fragment ions were allowed to have a mass deviation of 0.8 Da. False discovery rates were assessed using the Percolator tool 39 within the Proteome Discoverer package. The results were filtered for peptide rank 1 and high identification confidence, corresponding to a 1% false discovery rate. Low-scoring peptides (Mascot ion score ≤ 20) were manually verified. In the rare cases in which a peptide was mapped to more than one protein sequence, both protein hits are reported. For reliable phosphorylation site analysis, all phosphopeptide hits were automatically re-analysed by the phosphoRS software 40 within the Proteome Discoverer software suite. All the phosphopeptides identified in the ClpP in vivo pull-down assays were manually inspected. For other samples, we considered a phosphorylation site to be localized when the reported phosphoRS probability was higher than 90%. When multiple peptide-spectrum matches (PSMs) were obtained for the same phosphopeptide, only the PSM presenting the best identification/localization score compromise is presented. The multiple redundant PSMs were ranked according to their phosphoRS probability score into three categories (90-94%, 94-97% and 97-100%); the PSM presenting the best Mascot score within the highest phosphoRS category achieved was reported. PSMs presenting wrong or inconclusive localizations were thus excluded from the final list of phosphopeptides. Multiply phosphorylated peptides were also excluded from the analysis, because they cannot be classified into 'phosphorylation type' categories.
For quantitative analysis of ClpP-trapped proteins, MS data were analysed using the MaxQuant software environment 41 , version 1.5.1.2, and its built-in Andromeda search engine 42 , against the B. subtilis Uniprot database described above. Strict trypsin specificity with up to two missed cleavages was used. The minimum required peptide length was set to six amino acids. Carbamidomethylation of cysteine was set as a fixed modification and N-acetylation of proteins N termini (42.010565 Da) and oxidation of methionine were set as variable modifications. During the main search, parent masses were allowed an initial mass deviation of 4.5 p.p.m. and fragment ions were allowed a mass deviation of 0.5 Da. The mass accuracy of the precursor ions was improved by time-dependent recalibration algorithms of MaxQuant. The 'match between runs' option was enabled to match identifications across samples within a time window of 2 min of the aligned retention times. The second peptide identification option in Andromeda was enabled. PSM and protein identifications were filtered using a target-decoy approach at false discovery rate of 1% for PSMs and 5% for proteins. Relative, label-free quantification of proteins was done using the MaxLFQ algorithm 43 integrated into MaxQuant using default parameters. Unique and razor peptides were considered for quantification.
Statistical evaluation of the resulting protein quantifications was performed using R scripting. Proteins quantified in less than 50% of the samples were filtered out. Missing LFQ values were substituted by the lowest value observed in the corresponding sample. For each protein, the fold change of LFQ-averaged intensities (ratio ClpP TRAP /control) and the corresponding P value (Limma test; Linear Models for Microarray Data) were calculated. A protein was considered to be a ClpP substrate when it was found to be enriched in the TRAP pull-down assays by a factor of at least 2 and P < 0.05. The 'protein groups' output file from MaxQuant containing the statistical evaluation is available in Supplementary Table 1 . The mass spectrometry data have been deposited to the ProteomeXchange Consortium via the PRIDE partner repository 44 (http://proteomecentral.proteomexchange.org). Representative spectra of the pArg peptides identified in the ClpP trapping mutant pull-downs are presented in Supplementary Fig. 1 . Expression and purification of recombinant proteins. For the overexpression of recombinant proteins in E. coli BL21 (DE3), LB cultures were grown at 37 °C until the exponential phase, when expression was induced with 0.5 mM IPTG. After expression, cells were collected by centrifugation, resuspended in buffer A and stored at − 80 °C. As the B. subtilis ClpC protein was unstable when expressed in E. coli, the production of wild-type ClpC(6His) and ClpC EA (6His) was performed in B. subtilis containing the corresponding pHCMC05 plasmids, by induction with 1 mM IPTG for 3 h at 37 °C. The optimal expression strategies and purification buffers are summarized in Extended Data Table 3 .
Cell suspensions were incubated on ice for 30 min in the presence of 1 mg ml −1 lysozyme, 0.1 mM PMSF, 10 μ g ml −1 DNase and sonicated. Lysates were cleared by centrifugation and loaded on a 5 ml Ni-or Co-NTA column (GE Healthcare LifeSciences) equilibrated in buffer A. Washes were performed using a stepwise imidazole gradient, typically starting with 25 mM. The His-tagged proteins were eluted with buffer A containing 250 mM imidazole and concentrated using Vivaspin devices (Sartorius Stedim Biotech). Constructs expressed as a SUMOfusion (SUMO-ClpP and SUMO-MecA) were incubated with SUMO Protease (Thermo Fisher Scientific) to obtain tag-free versions of the proteins. All resulting proteins were further purified by gel filtration on a Superdex-75 or -200 column (GE Healthcare LifeSciences) equilibrated with buffer B. For the purification of McsA(6His), the full-length protein was separated from an abundant cleavage product by ion exchange on a MonoQ column (GE Healthcare LifeSciences) using a 0.1-1 M NaCl gradient in 50 mM Tris, pH 8.5, 1 mM TCEP. All proteins were aliquoted and stored at − 80 °C until further use.
For the purification of the B. subtilis ClpC NTD and NTD EA mutant, affinity, ion exchange, and size exclusion chromatography were carried out in a 0.5× PBS buffer (6 mM Na/K phosphate, pH 7.25, 1.35 mM KCl, 68.5 mM NaCl). After elution from Ni-NTA using the PBS buffer supplemented with 250 mM imidazole, the protein was passed through a ResourceQ column (GE Healthcare LifeSciences). This was followed by gel filtration on a Superdex 200 column (GE Healthcare LifeSciences). In vitro pull-down assays. Varying amounts of the analysed components (individual proteins, pArg AA ) were incubated in 200 μ l of reaction buffer (10 mM Tris, pH 8.0, 50 mM NaCl, 5 mM MgCl 2 and 25 mM imidazole). After 5 min, 50 μ l of Ni-Sepharose was added to capture His-tagged proteins. Sepharose was washed three times with 200 μ l reaction buffer and bound proteins were eluted with 50 μ l of elution buffer (10 mM Tris, pH 8.0, 50 mM NaCl, 5 mM MgCl 2 and 1 M imidazole). For visualization, input and elution, fractions were analysed by SDS-PAGE. Native-PAGE. For the analysis of the oligomeric state of purified ClpP samples, a Tris-acetate non-denaturing PAGE system was used. Gel composition corresponded to 7, 10 or 15% acrylamide, 0.24% bis-acrylamide, 200 mM Trisacetate, pH 7, polymerized in the presence of 0.042% ammonium persulfate (APS) and 0.125% N,N,N′ ,N′ -tetramethylethylenediamine (TEMED). The running buffer composition was 25 mM Tris-HCl, 192 mM glycine, pH 8.3. Protein separation was performed at 4 °C and 150 mV for 3-4 h, and proteins were visualized by Coomassie-based InstantBlue protein stain (Expedeon). The NativeMark unstained protein standard (Thermo Fisher Scientific) was used for the estimation of ClpP oligomeric state. Purification of casein pArg . To produce the arginine-phosphorylated substrate, β -casein from bovine milk (Sigma) was incubated at 10 μ M (all protein concentrations, if not otherwise mentioned, are for a single protomer) with 2 μ M McsB and McsA from B. subtilis in 25 mM Tris, pH 7.5, 50 mM NaCl, 20 mM MgCl 2 , and 5 mM ATP at 30 °C for 2 h. The reaction mixture was concentrated with a Vivaspin device and applied to a Superdex-200 size exclusion column equilibrated with 25 mM Tris, pH 7.5, 50 mM NaCl. The fractions most strongly enriched in β -casein over McsB (Extended Data Fig. 5a ) were then pooled, concentrated and stored at − 80 °C. The presence of the pArg modification was confirmed by immunoblotting using a pArg-specific antibody as described below.
To obtain casein pArg of higher purity, a similar phosphorylation reaction was performed, except that 4 μ M of the G. stearothermophilus McsB(6His) was used instead of the B. subtilis McsBA complex. The reaction mixture was afterwards applied to a Ni-NTA column (GE Healthcare LifeSciences) to reduce the amounts of the His-tagged McsB before the final gel filtration purification step (Extended Data Fig. 5c ).
To prepare β -casein phosphorylated to different degrees (Fig. 4e) , a large-scale phosphorylation reaction was set-up with the B. subtilis McsBA at 30 °C. An aliquot (time 0) was collected before the addition of ATP. After adding ATP, aliquots were taken after 10, 30, 60 and 120 min. After adding 100 mM EDTA (to stop phosphorylation), each aliquot was concentrated by Vivaspin ultrafiltration and applied to a Superdex 200 size exclusion column. An additional sample, which was collected after 120 min incubation with McsBA, was treated with 1 μ M YwlE arginine phosphatase for 2 h. The phosphatase was then inactivated by adding 2 mM pervanadate and the sample was concentrated and submitted to size exclusion chromatography. The different casein pArg preparations were concentrated and stored at − 80 °C. To quantify the increase of arginine phosphorylation over time, a western blot was performed using the pArg-specific antibody described previously 24 . The casein pArg preparations (2 μ g) were separated by SDS-PAGE, transferred to a nitrocellulose membrane and fixed using a 0.4% formaldehyde solution in PBS, pH 7.5, for 30 min as previously described 45 . After blocking, the pArg-specific primary antibody (2 μ g ml
, Morphosys AG) was incubated overnight at 4 °C and the secondary antibody (goat anti human IgG F(ab′ )2:HRP, AbD Serotec) was used at a 1:7,000 dilution for 1.5 h at room temperature. The detection was performed using ECL Plus western blotting substrate (Pierce). The signals were quantified using the ImageJ software 46 and normalized to the band intensities observed in a coomassie-stained SDS-PAGE gel replicate having 1.3 μ g of each protein preparation. ClpCP in vitro degradation assays. In vitro degradation assays containing 0.16 μ M ClpC (hexamer), 0.16 μ M ClpP (heptamer) and 5 μ M β -casein substrate were performed in 25 mM Tris, pH 7.5, 150 mM NaCl, 20 mM MgCl 2 and 5 mM ATP at 30°C. A different β -casein concentration (10 μ M) was used, for better resolution, when comparing ClpCP and ClpCP EA in MecA-dependent degradation. Small molecule compounds, for example, phospho-l-arginine (pArg AA , Toronto Biochemicals), l-arginine (Sigma) or sodium phosphate, pH 7.5, were added at 1 mM. Time-point aliquots were mixed with denaturing SDS-PAGE sample buffer containing 100 mM EDTA to stop the reaction and analysed by SDS-PAGE. The resulting gels were stained with InstantBlue dye (Expedeon) and quantified using ImageJ 46 . Supplementary Fig. 2 shows full SDS-PAGE gels and corresponding quantifications of ). All activity data represent a minimum of three independent experiments and the variability is highlighted as standard deviation. ITC. ITC measurements were performed using VP-ITC (Microcal). Ligands (pArg AA , l-arginine, phospho-l-tyrosine (pTyr AA , from Sigma), and sodium phosphate, pH 7.5, were prepared at 0.3-1.4 mM in 25 mM Tris, pH 8, 50 mM NaCl, 0. The optimized crystallization solution contained 13.5% (w/w) polyethylene glycol 4000, 500 mM ammonium sulfate, and 100 mM sodium acetate at pH 5. Crystals formed overnight at 19 °C and were soaked/cryo-protected in 40% polyethylene glycol 400, 20 mM Tris pH 8, and 6 mM pArg AA before being flash-frozen. Diffraction data to 1.6 Å were collected at 100 K using a wavelength of 0.9763 Å at beamline P14, DESY, Hamburg and integrated with XDS 48 . . N(omega)-phospho-l-arginine structure and constraints were obtained with the respective SMILES code using eLBOW 55 . Rounds of refinement in Phenix 56 and rebuilding in Coot yielded the final model with good statistics and geometry (Extended Data Table 2 and the following Ramachandran statistics: 98% favoured, 2% allowed, 0% outliers, 0% rotamer outliers). The featured-enhanced map, which is based on a composite residual omit map, was used to show ligand density. Figures were produced in Pymol 57 .
Purification of B. subtilis protein aggregates.
For the phosphoproteomic analysis of B. subtilis protein aggregates, a 3-l culture of B. subtilis was grown at 37 °C until late exponential phase and then heat-shocked (50 °C) for 45 min. Cells were collected by centrifugation, resuspended in 25 mM Tris, pH 7.5, 150 mM NaCl, 0.5% Triton X-100 and stored at − 80 °C.
A 30-ml cell suspension in 25 mM Tris, pH 7.5, 150 mM NaCl, 0.5% Triton X-100 was incubated on ice with 3 mg ml −1 lysozyme, Complete protease inhibitor cocktail (Roche), 20 μ g ml −1 DNase, 0.2 mM PMSF and 2 mM vanadate for 30 min. After dilution to 100 ml, cells were gently lysed at 4 °C by French Press (Constant Cell Disruption Systems) at 1.7 kbar. Lysis efficiency, estimated by plating out serial dilutions, exceeded 99%. The lysates were centrifuged at 45,000g for 30 min. The resulting pellets, containing insoluble protein aggregates, were further washed with 20 ml lysis buffer containing 0.4 mg ml −1 lysozyme, 10 μ g ml −1 DNase, 0.2 mM PMSF and 2 mM vanadate. After 40 min homogenization at 4 °C under gentle agitation, the pellets were re-centrifuged. The protein aggregates contained in the pellets were then solubilized in 7 ml 25 mM Tris, pH 7.5, 8 M urea by sonication. The samples were again centrifuged to separate the urea-solubilized protein aggregates from cell debris. The resulting supernatants were stored at − 80 °C until MS sample processing. Thermotolerance assay. To test the role of ClpC during heat stress, the following B. subtilis strains were investigated: wild type + pHCMC05, Δ clpC::tet + pHCMC05, Δ clpC::tet + pHCMC05-ClpC and Δ clpC::tet + pHCMC05-ClpC EA . For all experiments, cultures were grown at 37 °C in LB media containing 10 μ g ml −1 chloramphenicol and 0.2 mM IPTG. After reaching exponential phase, the cultures were transferred to a pre-warmed incubator at 53 °C for 0, 30, 60 or 120 min, respectively. After heat stress, the samples were diluted sequentially and transferred to LB plates. To compare the survival rate after heat stress, we determined the number of colony-forming units (CFU). All experiments were independently performed three times and the observed variability is highlighted as standard deviation.
Native mass spectrometry. Native mass spectrometry experiments were carried out on a Synapt G2Si instrument (Waters) with a nano-electrospray ionization (nESI) source. Mass calibration was performed by a separate infusion of NaI cluster ions. Solutions were ionised through a positive potential applied to metal-coated borosilicate capillaries (Thermo Scientific). β -casein samples (5 μ M) were sprayed from 25 mM ammonium acetate, pH 6.8. The temperature settings were capillary voltage 1.5 kV, sample cone voltage 30 V, extractor source offset 46 V, and source temperature 50 °C. Data were processed using Masslynx V4.1 software. Data reporting. Source Data for Figs 1-5 are provided in the Supplementary Information. No statistical methods were used to predetermine sample size. The experiments were not randomized, and investigators were not blinded to allocation during experiments and outcome assessment.
